Beta
55386

The Role of Concomitant Mastoidectomy in Improving Outcomes Following Tympanic Membrane Perforation Repair: A Systematic Review

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

-

Abstract

Abstract
Background: The role of mastoidectomy performed with tympanoplasty for tympanic membrane perforations in the absence of cholesteatoma remains controversial. Many otolaryngologists continue to routinely perform mastoidectomy with tympanoplasty, others argue that performing mastoidec-tomy in these patients is unnecessary, does not improve surgical outcomes, and subjects patients to increased surgical risks.
Aim of the Work: To assess the effectiveness and safety of performing routine cortical mastoidectomy in addition to tympanoplasty in treatment of tympanic membrane perforation in cases of chronic suppurative otitis media in the absence of cholesteatoma.
Patients and Methods: Five randomized controlled trials with total of 610 participents were included of any age with chronic suppurative non cholestaetomatous otitis media, divided into two groups: Group A (received Tympanoplasty alone), Group B (Tymanplasty with cortical mastoidectomy).
Five outcomes measured namely (healing rate,hearing rate, tympanometric evaluation, rate if otorrhea, need for subsequent procedure).
Results: Articles reporting results of concomitant mas-toidectomy with tympanoplasty were identified. Five articles satisfied our eligibility criteria, there was no significant heterogeneity. Compared to the conventional method tympan-oplasty with cortical mastoidectomy was found to have a significantly higher rate of healing (odds ratio of 1.762 with a 95% CI of –1.115 to 2.787, no significant difference in post-operative air bone gap (SMD of .056 with 95% CI of –0.110 to 0.222), no significant difference in rate of otorrhea (odds ratio of 1.949 with a 95% CI of 0.528 to 7.192, no significant difference in post-operative tympanometry (odds ratio of type A, Astympanometry was 0.777 and a 95% CI of 0.278 to 2.179, no significant difference in rate of revision surgery (odds ratio 2.069 and a 95% CI of 0.178 to 24.075.
Conclusions: From the result s of our systematic review we advise for the use of tympanoplasty alone for treatment of non cholesteatomatous chronic otitis media.

DOI

10.21608/mjcu.2018.55386

Keywords

Tympanoplasty or myringoplasty and mastoidec- tomy or tympa – Nomastoidectomy

Authors

First Name

EMAN A. EBRAHIM, M.Sc.;

Last Name

HOSSAM S. EL-SHERIF, M.D.

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

SHAABAN B. MOHAMMED, M.D.;

Last Name

FATTHE A. ERFAN, M.D.

MiddleName

-

Affiliation

The Department of Otorhinolaryngology, Faculty of Medicine, Tanta University, Tanta, Egypt

Email

-

City

-

Orcid

-

Volume

86

Article Issue

March

Related Issue

8392

Issue Date

2018-03-01

Receive Date

2017-10-26

Publish Date

2018-03-01

Page Start

703

Page End

708

Print ISSN

0045-3803

Online ISSN

2536-9806

Link

https://mjcu.journals.ekb.eg/article_55386.html

Detail API

https://mjcu.journals.ekb.eg/service?article_code=55386

Order

90

Type

Original Article

Type Code

263

Publication Type

Journal

Publication Title

The Medical Journal of Cairo University

Publication Link

https://mjcu.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023